1. Home
  2. Food
  3. News & Events from HFP
  4. HFP Constituent Updates
  5. FDA Seeks Public Input on Potential Market Name Change for Certain Rockfish Species
  1. HFP Constituent Updates

FDA Seeks Public Input on Potential Market Name Change for Certain Rockfish Species

Constituent Update  

March 31, 2026  

The U.S. Food and Drug Administration is issuing a Request for Information today on a potential update to the acceptable market name for eighteen species of Sebastes, commonly known as rockfish. This action follows a congressional directive and aims to balance food safety, regulatory clarity, and industry interests through an evidence-based determination.

In November 2025, Public Law 119-37 was enacted, directing the FDA to engage with stakeholders regarding a potential name change for specific Sebastes species. The FDA maintains "The Seafood List," a guide for the food industry on acceptable market names for seafood sold in interstate commerce, to ensure that labeling is accurate. Currently, the acceptable market name for the genus Sebastes is "rockfish." However, the FDA has received inquiries from industry stakeholders requesting that the name be changed to "snapper." The FDA has identified several critical issues for consideration before any changes are made to the acceptable market name for these rockfish species. These include issues related to scientific classification, food safety and hazard identification, and labeling and allergens concerns.  

The FDA is seeking comprehensive information from all interested parties, including industry members, consumer groups, and state regulatory agencies. Through the RFI, the agency is posing a series of questions to gather data on the potential impacts of a potential name change. This information will be essential for making an informed decision that upholds public health, adheres to statutory authority, and preserves transparency for consumers while considering industry interests.

  • For a full list of the questions and species in question, and to provide comment, please visit Regulations.gov Docket No. FDA-2026-C-3071.

Submit written/paper submissions to:   
Dockets Management Staff (HFA-305)   
Food and Drug Administration   
5630 Fishers Lane, Rm 1061   
Rockville, MD 20852   
All submissions received must include the Docket No. FDA-2026-C-3071 

Back to Top